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The purpose of this study was to compare two different isoflurane (Iso) delivery systems – 
(i) end-tidal closed-loop target-controlled infusion (ETCLo-TCI) system and (ii) out-of-
circuit vaporizer (VOC) – in horses undergoing surgery.
Twenty-four horses undergoing scheduled surgery were enrolled in this study. Anaesthesia 
was maintained using Iso delivered either by a calibrated TEC 4 VOC vaporizer (group V, 
n = 14) or an ETCLo-TCI system (group I, n = 10). Data were collected within the first 
hour of anaesthesia on the consumption of Iso, the number of anaesthetist drug delivery 
adjustments (software changes to the vaporizer setting or FE’Iso target input), the number 
of fresh gas flow (FGF) changes and the time taken to reach the first FE’Iso target (1.5%) 
after induction. 
 The median consumption of Iso and the median consumption of Iso per kilogram of body 
weight (BW) during the first hour of anaesthesia were significantly lower in group I 
compared with group V (20.5 (9.3-31.4) vs 29.1 (21.5- 43.0)) mL, (P = 0.003), and 0.042 
(0.028-0.052) vs 0.062 (0.037-0.094) mL kg‾¹, (P = 0.009). The median number of 
anaesthetist drug delivery adjustments was significantly lower in group I compared with 
group V (1.5 (0-3) vs 4 (3-9)), (P = 0.0002). 
The focus was on the number of drug delivery adjustments required to reach and maintain 
the target end-tidal Iso concentration (FE’Iso) and Iso consumption within the study period.
The time taken by both delivery systems to reach the FE’Iso of 1.5% as first target was also
considered.
2
Keywords: horse; isoflurane; vaporizer; closed-loop; target controlled infusion
3
1. Introduction 
Quantitative anaesthesia is the delivery of the exact amount of anaesthetic required to 
maintain the desired depth of anaesthesia in the anaesthetized subject [1]. This technique 
has been shown to have some advantages over qualitative anaesthesia, such as easy and 
efficient monitoring of the uptake of anaesthetic vapours, a substantial reduction in 
pollution, reduced costs, and continuous measurement of O2 uptake and CO2 production [1].
Despite its reported advantages, quantitative anaesthesia using the low gas flow technique 
has been unpopular because there is a conflict between reducing the gap between the 
desired and actual drug concentration and minimizing agent consumption by decreasing the
fresh gas flow (FGF), particularly when using conventional anaesthesia machines [2]. 
Injecting a volatile agent, in its liquid form, This conflict is resolved when the volatile 
anaesthetic agent is administered by injecting it directly into the respiratory circle system 
[3]. However, though satisfactory results were obtained when quantitative anaesthesia was 
attempted by manual injection of a volatile liquid anaesthetic into a closed breathing circuit 
according to the square root of the time, there was a failure to predict the volatile 
anaesthetic uptake and cardiovascular depression [4-8]. 
Various experimental and commercial anaesthesia delivery systems using closed-circuit 
technology together with in-circle agent delivery have been described in the literature, with 
each study attempting to identify the criteria that could be used to achieve agent control and
delivery [3, 9, 10]. These computerized delivery systems should aim to allow the 
anaesthetist to obtain a particular concentration of anaesthetic by simply entering a value 
into the computer controlling the system. Target-controlled inhalational (TCI) anaesthesia 
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is a method of producing anaesthesia based on controlled infusion by using an inhalational 
anaesthetic delivery system, where the system automatically adjusts the anaesthetic agent 
concentration to achieve the desired target levels set by the user. Such a system has been 
found to reduce anaesthetic consumption, as well as the average time required to achieve 
the desired FE’ of the volatile agent and the number of drug delivery adjustments required 
to maintain anaesthesia [11]. 
A low-budget electronic prototype of an isoflurane (Iso) delivery system, an end-tidal 
closed-loop target-controlled infusion (ETCLo-TCI), was tested on horses undergoing 
various surgical procedures [12]. The anaesthetist had only to input the desired FE’Iso 
(ETtarget***) into the anaesthetic delivery system and set the FGF manually. Iso was 
directly injected into the breathing system by a closed-loop system, comprising a laptop 
computer (with dedicated software), a computer-controlled syringe driver (loaded with 
liquid Iso) connected to the inspiratory arm of a large-animal circle breathing system and a 
respiratory gas monitor providing Iso end-tidal concentrations (FE’Iso) every 20 seconds to
the computer (Figure 1). This system works by administering an initial loading dose, based 
on Lowe’s equation [13], which is simply calculated by considering the total volume of the 
breathing system and the ventilator bellows, the functional residual capacity and the target 
FE’Iso and roughly estimating the cardiac output (CO). The anaesthesia infuser delivery 
system then injects Iso every minute in order to maintain the target FE’Iso. This system 
proved to be sufficiently accurate and easy to use [12]. 
The aim of this study was to assess during the first hour of inhalational anaesthesia whether
the ETCLo-TCI system provides some advantages over a VOC vaporizer, in terms of the 
amount of Iso consumed, the number of drug delivery adjustments required and the time 
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needed to reach the targeted FE’Iso in horses undergoing surgery.
2. Materials and Methods
The institutional Ethics Committee of the University of Padua discussed and approved the 
study procedure (Protocol number 69012; 2009; Tit III; Cl. 11; Fasc. 10).
Owners were informed about the ongoing nature of the study and signed the anaesthesia 
consent form. The estimated sample size to detect a difference in the primary endpoint 
(isoflurane consumption in one hour of anaesthesia) with a power of 80% and an alpha 
error of 5% in a two-independent group study design was calculated using commercially 
available software (Statistica, Statsoft IT). The effect size calculation was obtained 
assuming a hypothesized mean difference of 8 mL, with a standard deviation of 6.5 mL. 
The calculated minimum sample size was 10 subjects for each group.  Horses recruited for 
this study were undergoing isoflurane-maintained general anaesthesia for scheduled 
surgical procedures. Only horses positioned in dorsal recumbence position dorsal 
recumbency were enrolled for this study.
2.1 Anaesthetic technique
Horses were randomly assigned to group I or group V. Subjects assigned to the former 
group were maintained in anaesthesia using the ETCLo-TCI system, while those assigned 
to group V were anaesthetized with an isoflurane VOC vaporizer (TEC 4; Ohmeda, 
Finland). It was noted on the anaesthesia record if the subject being anaesthetized was the 
first case of the day. The health of the horses was determined by their history and a physical
examination. The physical status of the horse (American Society of Anesthesiologists 
(ASA) classification) was recorded, as well as its body weight. Food, but not water, was 
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withheld for 10–12 h before anaesthesia. All horses received acepromazine (0.02 mg kg‾¹; 
Prequillan; Fatro, Italy) and phenylbutazone (4.4 mg kg‾¹; Bute; ACME, Italy) 
intravenously (IV), via a previously inserted 12 G jugular catheter, 30 minutes before 
induction. This was followed by the administration of either romifidine (0.08 mg kg‾¹; 
Sedivet, Boehringer Ingelheim, Germany) or xylazine (1 mg kg‾¹; Sedaxylan 2%; Vetem 
Eurovet Animal Health, United Kingdom). Ketamine (2.2 mg kg‾¹; Ketavet 100, Intervet 
Productions, Italy) and diazepam (0.060 mg kg‾¹; Diazepam Hospira, Hospira Italia, Italy) 
were used to induce anaesthesia in all of the horses. After orotracheal intubation, the cuff 
was inflated and the horse was connected to a large-animal breathing system (Rotatorio 
Grossi Animali; SAMED, Italy). The horse was then placed in a dorsal recumbency on the 
operating table.
The breathing system comprised a standard large-animal circle anaesthetic system that 
included an integrated ventilator with descending bellows (Ventilatore Grossi Animali; 
SAMED, Italy). In order to detect potential leakages the system was filled with oxygen 
until a pressure of 25 cm H2O was reached. In order to detect potential leakages, the system
was pressure checked at 25 cmH2O.
To maintain the end-tidal carbon dioxide concentration (FE’CO2) below 5.2 kPa and to 
guarantee a more stable and predictable Iso uptake, positive-pressure ventilation  was 
immediately started at a peak inspiratory pressure of 20 cmH2O, with a respiratory 
frequency ranging between 7 and 8 breaths per minute. A respiratory gas monitor 
(Cardiocap Ultima; Datex-Ohmeda, Finland) was used to continuously measure the 
following respiratory variables: inspired (FI’O2) and expired (FE’O2) oxygen fractions, 
FE’CO2, respiratory frequency (fR), end-tidal (FE’Iso) and inspired fractions (FI’Iso) of 
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Iso. The respiratory gas monitor was calibrated every 6 months by a General Electric (GE) 
authorized engineer using a GE proprietary calibrating gas cylinder connected to the 
monitor’s sampling line. A Cardiocap II (Datex-Ohmeda, Finland) was used to 
continuously monitor the heart rate and arterial blood pressure and each variable was 
recorded at 5-minute intervals. A facial or transverse facial arterial catheter connected to a 
pressure transducer (Pressure Transducer DTX/Plus; Becton Dickinson) positioned and 
zeroed at the level of the sternal manubrium was used for invasive arterial blood pressure 
measurement. Once the first FE’Iso target (ETtarget) was attained (1.5%), the subsequent 
ETtarget adjustments were based on clinical signs of anaesthesia depth. When the anaesthesia 
plane was either inadequate too light (brisk palpebral (blinking) reflex, presence of 
swallowing, tightening of neck muscles) or excessive (i.e. when the eye globe was central 
and the palpebral and/or the corneal reflex was absent), the ETtarget Iso concentration was 
increased or decreased by 0.2%, respectively. If the mean arterial pressure was lower than 
70 mm Hg, dobutamine (Dobutamina Hospira; Hospira, Italy) was infused, starting at 0.6 
µg kg−¹ minute‾¹, and adjusted every 10 minutes up to a maximum infusion rate of 1.2 µg 
kg−¹ minute‾¹. Mean arterial blood pressure was maintained between 70 and 90 mmHg by 
adjusting the dobutamine infusion. 
If the horses displayed nystagmus or resisted the ventilator, a ketamine bolus was 
administered (0.1–0.2 mg kg‾¹) IV, or thiopental (0.5–1 mg kg‾¹) IV was injected if they 
moved. Morphine was administered IV (0.1 mg kg‾¹); Morfina Cloridrato Molteni, Italy) 
10–20 minutes before the end of surgery. 
2.1.1 Group I
The infusion system comprised a laptop computer, which was connected to a recently 
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calibrated respiratory gas monitor (Capnomac Ultima) for downloading and processing 
physiological data and to a syringe pump (Graseby 3500 Anaesthesia Pump; Smiths 
Medical International, United Kingdom) to control Iso infusion.
A 50-mL plastic syringe, filled with liquid Iso (Isoba; Schering-Plough, United Kingdom), 
was connected to the inspiratory branch (3 cm diameter, 170 cm long) of a large-animal 
plastic breathing hose, near the inspiratory valve, via a fine-bore extension tubing (Lectro-
Spiral Polyethylene Coiled I.V. Extension Set; Vygon, France) and an 18 G needle. To 
avoid any inadvertent drainage of liquid anaesthetic into the circuit, the syringe driver was 
positioned below the level of the injecting port. To ensure that liquid anaesthetic did not 
reach the patient, the injection point was below the level of the endotracheal tube. The hose 
was positioned in such a way as to maintain the needle in an absolutely vertical position 
during anaesthesia. A 2-cm diameter metallic plate, fixed within the hose at the opposite 
side of the 18G needle, was used for the collection of Iso drops. Respiratory gas was 
continuously sampled at the Y-piece by the gas monitor, and the sampled gas was then 
returned to the expiratory branch of the circuit after measuring.
The laptop computer, which used a Windows XP operating system ran a customized Visual
Basic C++ program which required the operator to enter the horse’s body weight (BW), the
breathing circuit volume (VCIRC), the functional residual capacity (VFRC), the blood-gas 
partition coefficient (B/G), the cardiac output (Qs) and the desired end-tidal Iso 
concentration (ET
target
). The program calculated the volume of Iso to be injected based on 
two equations. 
Volatile agent (mL) = [((VCIRC + VFRC) x ETtarget) + (ETtarget x B/G x Qs)]/206                          
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(1)
Equation 1 was used to determine the prime dose, where VCIRC (28,600 mL) was the total 
volume of the breathing system and ventilator, VFRC
 
(22 mL kg‾¹) 
was the functional 
residual capacity
 [14], cardiac output (Qs) was calculated according to Brody’s formula 
(200 x BW0.75) [15], and B/G (1.4) was the blood/gas partition coefficient. 
Isoflurane (mL) = [2 x B/G x (200 x BW0.75) x (ETtarget – ETmeasured) + (FGF – (BW0.75 x 0.07) 
x ETmeasured)]/206      
(2)                                                                                                                      
In order to correct the difference between the measured and the targeted Iso concentrations,
Equation 2 determined the volume of Iso to be administered every minute. The amount of 
volatile anaesthetic The amount of Iso flushed out by the FGF inflow every minute was 
computed in Equation 2. According to Kleiber [16], the basal oxygen uptake is determined 
to be 0.7 x 10 x BW0.75, which is then reduced by 30%, given that oxygen consumption 
decreases under anaesthesia [10].  The end-tidal Iso concentration, as a percentage of the 




The following data were displayed on the laptop monitor: the Iso infusion speed (mL hour-
1), the Iso volume to be next infused, the total infused Iso volume and ETmeasured. Re-entry of
the ETtarget
 
and FGF values was permitted at any stage during the procedure. The software 
also permitted the infusion to be paused or stopped at any time. 
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Iso administration was initiated by the activation of the delivery infusion system. An ETtarget
of 1.5% was set and the prime dose delivered over a 2-minute period. ETmeasured data, 
obtained from the gas analyser, were sent to the computer over a 1-minute period once the 
prime dose was delivered. Then, based on Equation 2, Iso was delivered as an infusion over
20 seconds, while taking account of the fact that the lowest end-tidal concentration of Iso 
received by the computer is ETmeasured. Following complete infusion of the prime dose, the 
FGF of oxygen (100%) was set at 4 L minute-1 until an inspired fraction of 0.7 was 
achieved, following which the rate was then reduced to 2 L minute-1. Any change in FGF in
this group was double counted as FGF adjustment required because the anaesthetist not 
only had to modify the flowmeter but also to manually enter the new FGF into the system 
every time it was changed. 
A VOC system (TEC 3; Ohmeda, Finland) was available for use if the anaesthetist 
discontinued the liquid Iso delivery for any reason.
2.1.2 Group V
Iso was delivered using a VOC vaporizer (TEC 4; Ohmeda, Finland) throughout the 
experimental study. The vaporizer was always refilled while in the same position, leaning 
against the edge of a horizontal surface delineated by red tape stripes. A bottle of Iso was 
connected to the vaporizer and positioned lower than the leaning plane such that, once the 
inlet valve was opened, all of the Iso decanted completely from the vaporizer into the 
bottle. Once the flow of Iso ceased, the inlet valve was closed and the bottle was 
disconnected. A prefilled bottle containing 50 mL of Iso was sequentially connected and 
again all the fluid was introduced into the vaporizer. The anaesthetist was free to use the 
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preferred FGF rate and to adjust the vaporizer setting in order to reach and maintain the 
desired FE’Iso target of 1.5%. When the depth of anaesthesia needed to be altered, the 
anaesthetist was again free to set the vaporizer and FGF as preferred. Similarly to group I, 
FE’Iso was varied by a 0.2% step: if the first FE’Iso target (1.5%) was insufficient to 
provide an adequate anaesthetic plane, FE’Iso was raised to 1.7%. Once the fraction of 
inspired oxygen was 0.7 and the plane of anaesthesia was stable (based on clinical signs), 
FGF was progressively reduced, aiming to set it to 2 L minute‾¹. Each variation in the 
vaporizer setting and FGF was recorded on the anaesthesia sheet. When the anaesthesia 
time reached 1 hour, the vaporizer in use was turned off, removed from the back bar and 
replaced with another prefilled Iso vaporizer (Tec 3 - Ohmeda). The amount of decanted 
Iso was measured with a 10-mL syringe under an extractor hood. The amount of consumed 
Iso was equal to 50 mL minus the decanted amount (mL). In this group, the time from 
opening the vaporizer to reaching the target FE’Iso of 1.5% was measured.
2.1.3 Recovery from anaesthesia
To assist recovery from anaesthesia, the horses were sedated with xylazine (0.3 mg kg‾¹; 
IV), while oxygen (15 L minute‾1) was administered intranasally. The duration of lateral 
and sternal recumbency, the time of extubation and the total time to standing following 
disconnection of the anaesthetic circuit were noted. Descriptors of the horses' recoveries 
were used to assign a "recovery score" to each horse, using a scale ranging from 1 to 5,with
5 being the best (horse stood easily after one attempt during recovery from anaesthesia) and
1 being the worst (horse could not stand without sling support or sustained significant 
injury during recovery) [17].
2.2 Statistical analysis 
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Data were analysed using a commercially available statistical package (SAS 9.3, SAS 
Institute). Categorical variables were expressed as frequencies and percentages. The 
correlation between the linear variables – BW and consumed Iso expressed in millilitres – 
was evaluated with Pearson’s correlation coefficient. Continuous variables were checked 
for normal distribution by visual inspection of bar graphs, histograms and the Shapiro-
Wilk test. Normally distributed variables were reported as the mean ± the standard 
deviation (SD), whereas non-normally distributed variables were expressed as the median 
(range). Differences between non-normally distributed data were analysed with the Mann-
Whitney test. Statistical significance was set at P < 0.05. The data are presented as box-
and-whisker plots, where the triangle represents the mean and the horizontal line the 
median, the box ends represent the interquartile range, and the upper and lower lines (or 
whiskers) represent the maximum and minimum values of data collected in each group.
3. Results 
Twenty-five horses, classified as ASA I on physical examination, were enrolled in this 
study; one horse in group I was excluded because the computer malfunctioned during the 
anaesthetic procedure. As a consequence, 24 horses – 7 intact males, 3 geldings and 14 
intact females undergoing scheduled surgical procedures – were included in the study. Of 
these, 10 were assigned to group I and 14 to group V. Both groups were similar in terms of 
age, body mass and number of subjects anaesthetized as first of the day (Table 1). Horses 
belonging to group I underwent the following procedures: arthroscopy (n= 8), desmotomy 
(n = 2), while, the group V procedures were: arthroscopy (n = 11), splint removal (n = 1), 
cataract surgery (n = 1), bone marrow collection and bone marrow concentrate aspirate 
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injection (n = 1).
Gas leakage from the breathing system was less than 0.5 L min-1 at 25 cmH2O when tested. 
Data on the amount of volatile anaesthetic consumed during the surgical procedure for one 
horse in group V were lost due to the aforementioned system crash. 
Three horses in group I and two in group V received xylazine during premedication. Four 
horses in group I and five in group V received ketamine during maintenance of anaesthesia.
Thiopentone was administered once to a horse in group I.
Dobutamine was administered to six out of 10 (60%) and 10 out of 14 (71.43%) horses, 
respectively, in groups I and V.
At the beginning of the anaesthesia, the median FGF in group V was 8 (7-10), while the 
median setting of the vaporizer was 4 (3.5-4). The median consumption of Iso, during the 
first hour of surgery, was significantly lower in group I compared with group V (20.5 (9.3-
31.4) mL vs 29.1 (21.5- 43.0) mL, P = 0.003) (Figure 2), with a median consumption of 
volatile anaesthetic per kilogram of BW of 0.042 (0.028-0.052) and 0.062 (0.037-0.094) 
mL kg‾¹, respectively, in groups I and V, (P = 0.009).
The median numbers of FE’Iso target variations during anaesthesia were the identical in the
two groups – 1(0-3). The median numbers of total drug delivery adjustments required by 
the ETCLo-TCI system in group I and the vaporizer in group V in the first hour of 
anaesthesia were significantly different (group I 1.5 (0-3) vs group V 4 (3-9), P = 0.0002) 
(Figure 3). No statistical difference was found between the two groups concerning the 
number of FGF adjustments required (group I 2 (1-7) vs group V 3 (2-7), P = 0.19).
A significant correlation between the total consumption of Iso in 1 hour and BW was 
observed in group I (R2 = 0.92, Pearson’s coefficient 0.96, P <0.001, 95% CI 0.82 to 0.99) 
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(Figure 4), but not in group V (R2 = 0.21, Pearson’s coefficient – 0.46, P<0.001, 95% CI – 
0.80 to 0.14).
No significant difference was found in the time taken by both systems for volatile 
anaesthetic delivery to reach the end-tidal target (group I 8 (6-16) vs group V 10 (4-15) (P 
= 0.69).
There was no significant difference regarding the quality of the recovery phase between 
groups I and V, as assessed by the recovery scores. In group I, six horses received a 
recovery score of 5, three of 4 and one of 3, while, in group V, nine horse received a 
recovery score of 5, three of 4 and two of 3. 
4. Discussion
This is the first published study to compare an electronic anaesthesia infuser system to 
deliver inhaled agents with a what can be considered the “standard” in volatile agent 
delivery, the VOC system to maintain anaesthesia in horses This is the first published study
to compare an electronic anaesthesia infuser system with a VOC system for the 
maintenance of anaesthesia in horses.  Although, the ETCLo-TCI system is a low-budget 
prototype, made by connecting different pieces of equipment (anaesthetic monitor, a 
syringe driver and a personal computer) using simple software, this system has proven to 
provide some advantages over the VOC system. As is shown by the high correlation 
coefficient between the amount of Iso used to produce 1 hour of anaesthesia and horse 
weight, the ETCLo-TCI system produces quantitative volatile agent anaesthesia. Although 
quantitative anaesthesia is often associated, as shown in the literature, with the use of a 
closed-circuit breathing system [6], it has not previously been demonstrated for an ETCLo-
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TCI system. One advantage of the tested delivery system is that it is able to adapt the 
anaesthetic administered to the FGF set by the anaesthetist, because the FGF is used in 
Equation (2) to calculate the amount of Iso that has to be delivered One advantage of the 
tested delivery system is that it is able to adapt the anaesthetic administered to the FGF set 
by the anaesthetist as per Equation (2). In this study, it was decided to set the fraction of 
inspired oxygen (FiO2) to a value of 0.7 to decrease the risk of hypoxemia. Horses under 
anaesthesia develop a high pulmonary shunt fraction; a supra-physiological FiO2 can 
increase arterial blood saturation [18], even though some drawbacks of this strategy have 
been reported [19].  Low flow anaesthesia may cause a build-up of unwanted gas, such as 
methane or acetone, within the breathing system. It has been suggested that, when using 
this technique, the operator should periodically raise the FGF in order to decrease the 
concentration of contaminants [20]. However, in this study, once the FiO2 had reached 0.7, 
the FGF was lowered to 2 L minute‾¹ as it was then easier to detect a gas leakage from the 
breathing system because of the emptying of the ventilating bellows, and this may have had
a positive impact on reducing air pollution in the operating theatre. 
The ETCLo-TCI system crashed because the software malfunctioned in one case out of 11. 
This would be an unacceptable failure rate for a device used in clinical anaesthesia. 
However, the delivery system tested in this study is a prototype and has a degree of 
instability and software issues that need to be resolved.
The amount of Iso consumed in group I was significantly lower than in group V. Given that
a 250 mL bottle of Iso costs about 50 Euro, 2 Euro could be saved during the first hour of 
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anaesthesia per horse anaesthetized. A greater saving, however, would occur if sevoflurane 
were used. Although, this would not produce a significant reduction in anaesthesia costs, m
Monitoring the amount of inhaled agent consumed when performing quantitative 
anaesthesia may open new research fields. Under certain conditions, the uptake of volatile 
anaesthetics could theoretically be used to provide information on cardiac output [21]. 
Moreover, research into large-animal anaesthesia could be directed towards the design of 
inhalational anaesthesia work stations based on the technology used in this study, where 
anaesthetists simply set their targets (end-tidal agent and oxygen concentration), allowing 
the machine to calculate the exact amount of anaesthetic to deliver. The system would 
constantly monitor these values and automatically adjust the gas delivery and total flow to 
achieve and maintain the set target values. In this study, the large-animal circle breathing 
system was dismantled, cleaned and left to dry overnight once the last case of the day had 
recovered from anaesthesia. This ensured that the system did not contain any residual Iso at
the beginning of the following day. The first case of the day may have required more 
anaesthetic, and, for this reason, the authors wanted to record the number of first-of-day 
cases anaesthetized in this study.
Anaesthetic uptake from the lung by the blood also depends on cardiac output – the higher  
the output, the higher the uptake of anaesthetic by the blood. The substantial difference in 
cardiac output between groups I and V may have caused differences in the consumption of 
isoflurane, independent of the delivery system’s performance. Nevertheless, the percentage 
of horses that received dobutamine during the maintenance of anaesthesia was similar in 
both groups. When a volatile agent is administered by a vaporizer at the beginning of 
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anaesthesia, the anaesthetic concentration has to be significantly higher than the FE’Iso 
target, which should be adequate to maintain general anaesthesia. This is due to the fact that
the anaesthetic requirement is very high in this phase because the large-animal circle 
breathing system has to be filled with the anaesthetic, and this is also the period when the 
anaesthetic uptake by the patient is at its highest. There are two methods to provide an 
elevated amount of volatile anaesthetic using a VOC vaporizer as the delivery system over 
a short time – flushing the breathing system with a high FGF containing a concentration of 
the volatile agent vapour close to the FE’ of the volatile anaesthetic target and/or setting the
vaporizer to deliver a high concentration of the drug. Once a horse is adequately 
anaesthetized, the anaesthetist decreases the FGF and the percentage of volatile anaesthetic 
delivered by the vaporizer [22].  This entire process is time-consuming, requires repeated 
drug delivery adjustments and a considerable degree of expertise Delivering a volatile 
anaesthetic by direct injection as a liquid into the breathing system allows modulation of 
the delivery as desired.  ETCLo-TCI involves a two-step administration mode. Initially, a 
loading dose is delivered to raise the FE’Iso to a target value (1.5% in this study). When 
using a VOC vaporizer, the amount of wasted volatile anaesthetic is high at the beginning 
of anaesthesia and also rises every time the FE’ target has to be varied. In the later part of a 
surgical procedure, anaesthesia tends to be more stable and variations in the FE’Iso target 
are generally less frequent. The difference in Iso consumption between groups I and V 
would have been less pronounced if the second hour of anaesthesia were also taken into 
account.
 In order to avoid a potentially serious cardiovascular consequence, as previously reported 
[6], the loading dose was administered over 2 minutes. This can explain why there was no 
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significant difference in the time taken by both systems to reach the FE’Iso target. 
However, this lack of difference should be considered as a desirable safety feature of 
ETCLo-TCI. The second administration modality delivers on a minute-by-minute basis the 
amount of Iso that is necessary to raise the FE’Iso to the target. Therefore, the Iso delivery 
is completely independent of the FGF as the carrier, which can be set to achieve the desired
FiO2, as it was in this study. The number of FE’Iso target changes during the surgical 
procedures was similar in both groups; nevertheless, the required number of drug delivery 
adjustments differed significantly between both groups. The anaesthesiologist’s vigilance 
has been shown to decrease as the number of tasks increases [23, 24]. However, the use of 
the ETCLo-TCI system may reduce the time required by the anaesthetist to provide an 
adequate anaesthetic plane compared with systems that use a VOC vaporizer. In order to 
minimize the consumption of Iso in group V once the plane of anaesthesia was stable, the 
anaesthetist reduced the FGF by up to 2 L minute‾¹. This reduction in FGF may have forced
the operator to modify the vaporizer setting more often than normal to maintain the desired 
FE’Iso, thus potentially introducing a bias into this study. 
This study did not find differences in the number of FGF changes between the two groups. 
However, any changes in FGF were double counted in group I. This decision was taken for 
the reason expressed above. A more innovative version of this delivery system using an 
electronic flowmeter could avoid the manual input of the FGF value into the system – such 
a system would acquire the FGF value directly from an electronic flowmeter. Considering 
the non-relevance of FGF regarding anaesthetic administration when using the ETCLo-TCI
system, an upgraded version might just require the simple entry of the FiO2 target; the FGF 
could be automatically regulated by a closed-loop feedback system to achieve this target.  
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The anaesthetist was left free to premedicate horses with xylazine or romifidine. The 
shorter duration of action of xylazine may have caused the need for a higher FE’Iso in 
horses premedicated with this drug, increasing the number of drug delivery adjustments 
required compared with subjects receiving romifidine.
A greater number of horses in group V compared with group I had a recovery score of 5; 
however, it is very unlikely that the volatile agent delivery system would have played any 
role in the recovery quality from anaesthesia – this was influenced by other factors [17]. 
Erroneous high readings of anaesthetic agent concentrations can be caused by interfering 
with the anaesthetic gas analysis of methane [25, 26], which can accumulate in rebreathing 
systems in anaesthetized horses [27]. Methane absorbs infrared light at a wavelength of 3.3 
µm, which is the operating basis behind the use of infrared absorption technology to 
measure the concentration of volatile anaesthetic agents in a respiratory gas sample using a 
Capnomac Ultima gas analyser, as in this study. Dujardin et al. [28] found that methane 
builds up within the breathing system when a FGF as low as 1.5-2 L minute-1 is delivered, 
causing an associated error in the volatile anaesthetic concentration reading. Therefore, the 
FGF was kept low enough to potentially cause the build-up of methane within the breathing
system in both groups. FGF was lowered earlier in group V than in group I. When the 
ETtarget was raised in group V, the FGF may have also been raised. However, considering 
the number of ETtarget variations, the ETtarget value used during maintenance of anaesthesia, 
the number of ketamine and/or thiopentone boluses administered and the fact that the 
number of subjects treated with dobutamine did not differ, it is unlikely that possible 
differences in FGF in some subjects would have jeopardized the study results. Koenig et al.
[29] found ETCO2 to be a poor predictor of the partial pressure of CO2 (PaCO2) in arterial 
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blood in anaesthetized horses. Physiological dead space and intrapulmonary shunting can 
significantly affect the alveolar-arterial gradient of gases and vapours, introducing a 
variable source of error to the volatile anaesthetic end-tidal reading. As explained in the 
Materials and Methods section, the ETtarget was adjusted during anaesthesia maintenance 
based on clinical signs of depth of anaesthesia, regardless of the volatile anaesthetic Eend-
tidal reading displayed on the monitor. Based on all these facts, the authors consider it 
improbable that methane accumulation accounted for the inter-group differences. 
Considering the high FGF required to reach the desired FiO2, the fact that data were only 
collected for 1 hour of anaesthesia and the similar anaesthetic conditions for both groups, it 
is improbable that methane accumulation had either an effect on group comparison or on 
anaesthesia quality. The difference between the ETmeasured
 
and the Iso arterial blood 
concentration may well be increased by methane accumulated in the breathing system.
Koenig et al. [23] found ETCO2 to be a poor predictor of the partial pressure of CO2 
(PaCO2) in arterial blood in anaesthetized horses. Nevertheless, mechanically ventilated 
healthy horses have shown a minor mean difference in the alveolar-arterial pressure of CO2 
[23,24].
5. Conclusions
The use of electronic devices for anaesthetic dosing offers the opportunity to achieve 
precise dosing, while requiring less drug dosage and fewer adjustments by the anaesthetist. 
The ETClo-TCI system produces quantitative volatile agent anaesthesia, thus providing a 
simple means for anaesthetic uptake monitoring. Further studies should be directed towards
21
developing this volatile anaesthetic delivery system by adding an electronically controlled 
flowmeter.
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Fig. 1: The end-tidal closed-loop target-controlled infusion device (ETCLo-TCI) system. In
this system isoflurane is directly injected into the breathing system by a closed-loop system,
which comprises a laptop computer (with dedicated software), a computer-controlled 
syringe driver (loaded with liquid isoflurane) connected to the inspiratory arm of a large-
animal circle breathing system and a respiratory gas monitor.
Fig. 2: Number of isoflurane delivery device setting variations in the first hour of 
anaesthesia recorded  in 10 horses using an ETCLo-TCI delivery system (group I) and in 14
horses using a VOC vaporizer (group V).  Data collected are statistically significant (P < 
0.05) and presented as box-and-whisker plots.
Fig. 3: Median consumption of isoflurane (mL) in the first hour of anaesthesia recorded in 
10 horses using an ETCLo-TCI delivery system (group I) and in 14 horses using a VOC 
vaporizer (group V).  Data collected are statistically significant (P < 0.05) and presented as 
box-and-whisker plots. 
Fig. 4: Significant correlation (Pearson’s coefficient 0.96, P < 0.001, 95% CI 0.82 to 0.99) 
between the total consumption of isoflurane (mL) in the first hour of anaesthesia and the 
body weight in 10 horses using an ETCLo-TCI delivery system (group I). Data are 
presented in a scatter plot with regression line.
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